UBS AM
BLFS icon

UBS AM’s BioLife Solutions BLFS Stock Holding History

UBS AM’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
75,790
+7,993
+12% +$187K ﹤0.01% 2016
2026
Q1 		$1.29M Sell
67,797
-7,575
-10% -$167K ﹤0.01% 2233
2025
Q4 		$1.82M Sell
75,372
-4,882
-6% -$128K ﹤0.01% 1922
2025
Q3 		$2.05M Sell
80,254
-11,608
-13% -$275K ﹤0.01% 1740
2025
Q2 		$1.98M Buy
91,862
+27,446
+43% +$619K ﹤0.01% 2147
2025
Q1 		$1.47M Sell
64,416
-6,270
-9% -$165K ﹤0.01% 2142
2024
Q4 		$1.84M Buy
70,686
+8,258
+13% +$205K ﹤0.01% 2094
2024
Q3 		$1.56M Sell
62,428
-1,271
-2% -$30K ﹤0.01% 2174
2024
Q2 		$1.37M Buy
63,699
+20,779
+48% +$403K ﹤0.01% 2204
2024
Q1 		$796K Hold
42,920
– – ﹤0.01% 2119
2023
Q4 		$697K Buy
42,920
+4,736
+12% +$60.4K ﹤0.01% 2207
2023
Q3 		$527K Hold
38,184
– – ﹤0.01% 2276
2023
Q2 		$831K Hold
38,184
– – ﹤0.01% 2088
2023
Q1 		$831K Buy
38,184
+3,041
+9% +$68.4K ﹤0.01% 2088
2022
Q4 		$640K Hold
35,143
– – ﹤0.01% 2073
2022
Q3 		$800K Sell
35,143
-6,231
-15% -$133K ﹤0.01% 2100
2022
Q2 		$571K Buy
41,374
+10,258
+33% +$151K ﹤0.01% 2261
2022
Q1 		$707K Hold
31,116
– – ﹤0.01% 2310
2021
Q4 		$1.16M Hold
31,116
– – ﹤0.01% 2134
2021
Q3 		$1.32M Sell
31,116
-1,165
-4% -$56.1K ﹤0.01% 2028
2021
Q2 		$1.44M Buy
32,281
+3,781
+13% +$133K ﹤0.01% 2005
2021
Q1 		$1.03M Buy
28,500
+2,400
+9% +$94.9K ﹤0.01% 2078
2020
Q4 		$1.04M Buy
+26,100
New +$890K ﹤0.01% 1969

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS AM's BLFS Position: Q2 2026 in Review

UBS AM increased its BioLife Solutions (BLFS) stake by 12% in Q2 2026, buying an estimated $187K and bringing the position to 75,790 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

UBS AM first reported a position in BLFS in Q4 2020 and has held it in 23 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • UBS AM held 75,790 shares of BioLife Solutions worth $2.14M as of Q2 2026.
  • UBS AM bought 7,993 BioLife Solutions shares in Q2 2026, an estimated $187K.
  • BioLife Solutions made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2016 holding.
  • UBS AM first reported a position in BioLife Solutions in Q4 2020 and has held it in 23 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.